BACKGROUND AND OBJECTIVES: Recent progress in the development of diagnostic
techniques has greatly facilitated the monitoring of minimal residual disease (MRD) in …

The kinetics of minimal residual disease (MRD) and chimerism were studied in 15 patients
with chronic myeloid leukemia (CML) receiving nonmyeloablative stem cell transplantation …

Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …

We performed a two-step polymerase chain reaction (PCR) to detect bcr-abl-specific mRNA
in 440 peripheral blood and/or bone marrow samples of 30 chronic myeloid leukemia (CML) …

Twelve patients (9 males and 3 females) with chronic myelogenous leukemia, underwent
CD8+ T cell depleted allogeneic bone marrow transplantation with a sex-mismatched donor …

Detection of the chronic myelogenous leukemia (CML)-related marker, the bcr/abl m-RNA
transcript, in blood or bone marrow of patients with CML in hematologic remission after …

BACKGROUND AND OBJECTIVES: The role of hematopoietic chimerism after allogeneic
stem cell transplantation (SCT) for acute leukemia remains controversial. We studied the …

Allogenic stem cell transplantation (HCT) is a potentially curative treatment for patients with
various hematologic malignancies. Following HCT it is common practice to assess …

Donor hematopoiesis or donor chimerism in the host following allogeneic bone marrow
transplantation (BMT) has appeared crucial to the engraftment process. However, as …

Using in situ hybridization with an X and Y chromosome probe mixture, 106 bone marrow
samples from 38 patients with malignant and non-malignant hematological diseases who …